시장보고서
상품코드
1484867

세계의 저분자 주사제 시장 보고서(2024년)

Small Molecule Injectable Drugs Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 175 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

저분자 주사제 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2028년에는 CAGR 12.8%로 전망되며, 3,551억 4,000만 달러로 성장이 전망됩니다. 예측 기간 동안 예상되는 성장은 맞춤형 의료, 디지털 건강 솔루션 통합, 공급망 최적화, 실세계 증거 활용, 외래 환자 관리로의 전환과 관련이 있습니다. 이 기간에 예상되는 중요한 동향으로는 약물 전달 시스템의 진보, 기술 혁신, 연구 개발에 중점화, 주사 요법의 혁신, 신약 제제의 신속한 승인 등이 있습니다.

만성 질환의 유병률 증가는 당분간 저분자 주사제 시장의 큰 성장을 이끌 것으로 예상됩니다. 만성 질환은 장기간의 지속성 및 완만한 진행을 특징으로 하며, 앉기 쉬운 라이프 스타일, 건강에 해로운 식습관, 담배 사용, 스트레스 수준 상승 등의 요인에 의해 증가 경향이 있습니다. 이러한 라이프 스타일의 선택은 비만, 당뇨병, 심혈관 질환, 특정 암과 같은 질병의 출현에 기여합니다. 저분자 주사제는 표적 치료, 컴플라이언스 강화, 질병 변형, 병용 치료 옵션, 치료 모니터링 기회를 제공함으로써 만성 질환 관리에 매우 중요한 역할을 합니다. 예를 들어, 2023년 9월 세계보건기구(WHO)의 데이터에 따르면, 비감염성 질환(NCDs) 또는 만성질환은 세계 연간 사망자 수 4,100만 명의 74%를 차지합니다. 이 중 1,790만명이 심혈관 질환, 930만명이 암, 410만명이 만성 호흡기 질환, 200만명이 당뇨병에 의한 것으로, 저분자 주사제 시장의 성장의 원동력이 되고 있습니다.

저분자 주사제 시장 진출기업은 경구약에 함유된 유효성분의 용해성을 높이기 위해 미립자 기술 등 신기술의 개발에 주력하고 있습니다. 마이크로파티클 기술은 폴리머, 금속, 세라믹, 복합재료 등 다양한 재료를 이용하여 일반적으로 나노미터에서 마이크로미터 크기의 마이크로 스케일 레벨 입자를 설계, 제조, 응용하는 것입니다. 예를 들어, 2022년 3월 독일을 기반으로 하는 특수화학 제조업체인 Evonik Industries AG는 경구용 의약품에서 의약품 유효성분의 용해성 향상을 목적으로 하는 신규 미립자 기술인 EUDRATEC SoluFlow를 발표했습니다. 이 혁신적인 에멀젼 기반 공정 기술은 기존의 제조 방법이 직면했던 용해성 문제, 특히 화합물의 70% 이상이 불용성인 새로운 저분자 치료 문제를 해결합니다. EUDRATEC의 SoluFlow는 난용성 약물을 비정질 고체 분산체(ASD)의 유동성 분말로 전환시켜 암, 심혈관 질환, 감염, 당뇨병을 비롯한 다양한 치료 부문에서 새로운 경구 치료의 개발을 촉진합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나와 러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모 및 성장

  • 세계의 저분자 주사제 시장 : 촉진요인 및 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 저분자 주사제 시장 실적 : 규모 및 성장(2018-2023년)
  • 세계의 저분자 주사제 시장 예측 : 규모 및 성장(2023-2028년, 2033년)

제6장 시장 세분화

  • 세계의 저분자 주사제 시장 : 약제 클래스별 : 실적 및 예측(2018-2023년, 2023-2028년, 2033년)
  • 저분자 항생제
  • 진통제
  • 화학요법
  • 항바이러스제
  • 항응고제
  • 골격근 이완약
  • 항경련제
  • 기타
  • 세계의 저분자 주사제 시장 : 적응증별 : 실적 및 예측(2018-2023년, 2023-2028년, 2033년)
  • 통증 관리
  • 종양학
  • 감염증
  • 심혈관 질환
  • 중추신경질환
  • 기타
  • 세계의 저분자 주사제 시장 : 배달 방법별 : 실적 및 예측(2018-2023년, 2023-2028년, 2033년)
  • 점적 세트
  • 정맥 주사
  • 주입 펌프
  • 근육내 주사
  • 피하 주사
  • 세계의 저분자 주사제 시장 : 최종 사용자별 : 실적 및 예측(2018-2023년, 2023-2028년, 2033년)
  • 병원
  • 외래 클리닉
  • 외래 시설
  • 주입 치료 센터
  • 재택치료
  • 기타

제7장 지역별 및 국가별 분석

  • 세계의 저분자 주사제 시장 : 지역별 : 실적 및 예측(2018-2023년, 2023-2028년, 2033년)
  • 세계의 저분자 주사제 시장 : 국가별 : 실적 및 예측(2018-2023년, 2023-2028년, 2033년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 저분자 주사제 시장 : 경쟁 구도
  • 저분자 주사제 시장 : 기업 프로파일
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • F. Hoffmann-La Roche AG
    • Merck & Co. Inc.
    • AbbVie Inc.

제31장 기타 주요 기업 및 혁신 기업

  • Sanofi SA
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Abbott Laboratories
  • Novartis AG
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Becton Dickinson and Company
  • Teva Pharmaceutical Industries Ltd.
  • Baxter International Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병(M&A)

제35장 미래의 전망 및 잠재적인 분석

제36장 부록

AJY 24.06.05

Small molecule injectable drugs refer to pharmaceutical substances characterized by their small size and low molecular weight. These medications are typically administered via injection, including intravenous, intramuscular, or subcutaneous routes, to ensure systemic distribution throughout the body.

The primary types of drug classes within small-molecule injectable drugs encompass small-molecule antibiotics, analgesics, chemotherapy agents, antivirals, anticoagulants, skeletal muscle relaxants, anticonvulsants, and others. Small-molecule antibiotics, for instance, are antibacterial medications featuring a low molecular weight and simple chemical structure. These drugs find applications across various medical indications such as pain management, oncology, infectious diseases, cardiovascular diseases, central nervous system (CNS) disorders, among others. Delivery of small-molecule injectable drugs encompasses various methods including IV sets, intravenous injections, infusion pumps, intramuscular injections, and subcutaneous injections. These delivery modalities cater to diverse end-users including hospitals, ambulatory clinics, outpatient facilities, infusion therapy centers, home care settings, and others.

The small molecule injectable drugs market research report is one of a series of new reports from The Business Research Company that provides small molecule injectable drugs market statistics, including small molecule injectable drugs industry global market size, regional shares, competitors with a small molecule injectable drugs market share, detailed small molecule injectable drugs market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule injectable drugs industry. This small-molecule injectable drug market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The small molecule injectable drugs market size has grown rapidly in recent years. It will grow from $195.14 billion in 2023 to $220.85 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth witnessed in the historic period can be attributed to several factors, including the escalation of chronic diseases, an aging population demographic, government initiatives, the augmentation of healthcare expenditure, and enhancements in manufacturing processes.

The small molecule injectable drugs market size is expected to see rapid growth in the next few years. It will grow to $355.14 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The anticipated growth in the forecast period can be linked to personalized healthcare, the integration of digital health solutions, supply chain optimization, the utilization of real-world evidence, and a transition towards outpatient care. Significant trends expected in this period encompass advancements in drug delivery systems, technological innovations, heightened focus on research and development, innovation in injectable therapies, and expedited approvals of new drug formulations.

The escalating prevalence of chronic diseases is anticipated to drive significant growth in the small-molecule injectable drug market in the foreseeable future. Chronic diseases, characterized by prolonged persistence and gradual progression, are on the rise due to factors such as sedentary lifestyles, unhealthy dietary habits, tobacco use, and increasing stress levels. These lifestyle choices contribute to the emergence of conditions such as obesity, diabetes, cardiovascular diseases, and certain cancers. Small-molecule injectable drugs play a pivotal role in managing chronic diseases by providing targeted therapy, enhanced compliance, disease modification, combination therapy options, and opportunities for therapeutic monitoring. For instance, according to the World Health Organization's data in September 2023, non-communicable diseases (NCDs) or chronic diseases accounted for 74% of the 41 million global deaths annually. Among these, 17.9 million were due to cardiovascular diseases, 9.3 million to cancer, 4.1 million to chronic respiratory diseases, and 2.0 million to diabetes, underscoring the driving force behind the growth of the small-molecule injectable drug market.

Companies operating in the small-molecule injectable drug market are concentrating on advancing new technologies, such as microparticle technology, to enhance the solubility of active pharmaceutical ingredients in oral drug products. Microparticle technology involves the design, fabrication, and application of particles at the microscale level, typically ranging from nanometers to micrometers in size, using various materials such as polymers, metals, ceramics, and composites. For example, in March 2022, Evonik Industries AG, a Germany-based specialty chemicals company, introduced EUDRATEC SoluFlow, a novel microparticle technology aimed at improving the solubility of active pharmaceutical ingredients in oral drug products. This innovative emulsion-based process technology addresses solubility challenges faced by traditional manufacturing methods, particularly for new small-molecule therapeutics where over 70% of compounds are insoluble. EUDRATEC SoluFlow facilitates the development of new oral therapeutics across various therapeutic areas, including cancer, cardiovascular diseases, infectious diseases, and diabetes, by converting poorly soluble drugs into free-flowing powders of amorphous solid dispersions (ASD).

In September 2021, Ardena, a Belgium-based pharmaceutical company, acquired Idifarma from Suanfarma, a move aimed at bolstering Ardena's position as a comprehensive contractor offering integrated services across the clinical supply chain. Idifarma, a Spain-based pharmaceutical contract development and manufacturing company, specializes in the production of small-molecule injectable drugs, thereby complementing Ardena's capabilities and expanding its offerings in the pharmaceutical market.

Major companies operating in the small molecule injectable drugs market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, Fresenius Kabi AG, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals plc, BioCryst Pharmaceuticals Inc., Mylan N.V.

North America was the largest region in the small molecule injectable drugs market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small molecule injectable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the small molecule injectable drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small molecule injectable drugs market consists of sales of antineoplastic agents, hormones, and vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule Injectable Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule injectable drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule injectable drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule injectable drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Class: Small Molecule Antibiotics; Analgesics; Chemotherapy; Antivirals; Anticoagulant; Skeletal Muscle Relaxants; Anticonvulsants; Other Drug Class
  • 2) By Indication: Pain Management; Oncology; Infectious Diseases; Cardiovascular Diseases; CNS Diseases; Other Indications
  • 3) By Mode of Delivery: IV Set; Intravenous Injection; Infusion Pump; Intramuscular Injection; Subcutaneous Injection
  • 4) By End User: Hospitals; Ambulatory Clinics; Outpatient Facility; Infusion Therapy Center; Home Care; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule Injectable Drugs Market Characteristics

3. Small Molecule Injectable Drugs Market Trends And Strategies

4. Small Molecule Injectable Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Small Molecule Injectable Drugs Market Size and Growth

  • 5.1. Global Small Molecule Injectable Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Small Molecule Injectable Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Small Molecule Injectable Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Small Molecule Injectable Drugs Market Segmentation

  • 6.1. Global Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecule Antibiotics
  • Analgesics
  • Chemotherapy
  • Antivirals
  • Anticoagulant
  • Skeletal Muscle Relaxants
  • Anticonvulsants
  • Other Drug Class
  • 6.2. Global Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • CNS Diseases
  • Other Indications
  • 6.3. Global Small Molecule Injectable Drugs Market, Segmentation By Mode of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intravenous Set
  • Intravenous Injection
  • Infusion Pump
  • Intramuscular Injection
  • Subcutaneous Injection
  • 6.4. Global Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Clinics
  • Outpatient Facility
  • Infusion Therapy Center
  • Home Care
  • Other End Users

7. Small Molecule Injectable Drugs Market Regional And Country Analysis

  • 7.1. Global Small Molecule Injectable Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Small Molecule Injectable Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Small Molecule Injectable Drugs Market

  • 8.1. Asia-Pacific Small Molecule Injectable Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Small Molecule Injectable Drugs Market

  • 9.1. China Small Molecule Injectable Drugs Market Overview
  • 9.2. China Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Small Molecule Injectable Drugs Market

  • 10.1. India Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Small Molecule Injectable Drugs Market

  • 11.1. Japan Small Molecule Injectable Drugs Market Overview
  • 11.2. Japan Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Small Molecule Injectable Drugs Market

  • 12.1. Australia Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Small Molecule Injectable Drugs Market

  • 13.1. Indonesia Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Small Molecule Injectable Drugs Market

  • 14.1. South Korea Small Molecule Injectable Drugs Market Overview
  • 14.2. South Korea Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Small Molecule Injectable Drugs Market

  • 15.1. Western Europe Small Molecule Injectable Drugs Market Overview
  • 15.2. Western Europe Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Small Molecule Injectable Drugs Market

  • 16.1. UK Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Small Molecule Injectable Drugs Market

  • 17.1. Germany Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Small Molecule Injectable Drugs Market

  • 18.1. France Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Small Molecule Injectable Drugs Market

  • 19.1. Italy Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Small Molecule Injectable Drugs Market

  • 20.1. Spain Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Small Molecule Injectable Drugs Market

  • 21.1. Eastern Europe Small Molecule Injectable Drugs Market Overview
  • 21.2. Eastern Europe Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Small Molecule Injectable Drugs Market

  • 22.1. Russia Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Small Molecule Injectable Drugs Market

  • 23.1. North America Small Molecule Injectable Drugs Market Overview
  • 23.2. North America Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Small Molecule Injectable Drugs Market

  • 24.1. USA Small Molecule Injectable Drugs Market Overview
  • 24.2. USA Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Small Molecule Injectable Drugs Market

  • 25.1. Canada Small Molecule Injectable Drugs Market Overview
  • 25.2. Canada Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Small Molecule Injectable Drugs Market

  • 26.1. South America Small Molecule Injectable Drugs Market Overview
  • 26.2. South America Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Small Molecule Injectable Drugs Market

  • 27.1. Brazil Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Small Molecule Injectable Drugs Market

  • 28.1. Middle East Small Molecule Injectable Drugs Market Overview
  • 28.2. Middle East Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Small Molecule Injectable Drugs Market

  • 29.1. Africa Small Molecule Injectable Drugs Market Overview
  • 29.2. Africa Small Molecule Injectable Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Small Molecule Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Small Molecule Injectable Drugs Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Small Molecule Injectable Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Small Molecule Injectable Drugs Market Competitive Landscape
  • 30.2. Small Molecule Injectable Drugs Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. AbbVie Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Small Molecule Injectable Drugs Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Bristol-Myers Squibb Company
  • 31.3. AstraZeneca plc
  • 31.4. Abbott Laboratories
  • 31.5. Novartis AG
  • 31.6. Fresenius Kabi AG
  • 31.7. GlaxoSmithKline plc
  • 31.8. Eli Lilly and Company
  • 31.9. Gilead Sciences Inc.
  • 31.10. Amgen Inc.
  • 31.11. Becton Dickinson and Company
  • 31.12. Teva Pharmaceutical Industries Ltd.
  • 31.13. Baxter International Inc.
  • 31.14. Sun Pharmaceutical Industries Ltd.
  • 31.15. Aurobindo Pharma Ltd.

32. Global Small Molecule Injectable Drugs Market Competitive Benchmarking

33. Global Small Molecule Injectable Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Small Molecule Injectable Drugs Market

35. Small Molecule Injectable Drugs Market Future Outlook and Potential Analysis

  • 35.1 Small Molecule Injectable Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Small Molecule Injectable Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Small Molecule Injectable Drugs Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제